How does Atorvastatin affect lipid metabolism in autoimmune diseases, and can it help manage dyslipidemia in these conditions?
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Atorvastatin reduces cholesterol synthesis by inhibiting HMG-CoA reductase. In autoimmune diseases, it can help control dyslipidemia, potentially reducing cardiovascular risks.
Atorvastatin impacts lipid metabolism by lowering LDL levels and has been found effective in managing dyslipidemia in patients with autoimmune diseases, aiding in overall risk reduction.